- Patient Education: Video
NCCN Webinar : Know What Your Doctors Know: Multiple Myeloma - Part 1 to 11 and Q&A
Updated: May 9, 2022
Know What Your Doctors Know: Multiple Myeloma Part 1 - About NCCN and NCCN Foundation
Link to more videos below
NCCN: Know What Your Doctors Know: Multiple Myeloma - NCCN and NCCN Foundation
National Comprehensive Cancer Network (NCCN)
Jul 22, 2019
NCCN Guidelines for Patients
https://www.nccn.org/guidelines/patients
Know What Your Doctors Know: Multiple Myeloma Part 1 - About NCCN and NCCN Foundation
Know What Your Doctors Know: Multiple Myeloma Part 2 - Presenters
Know What Your Doctors Know: Multiple Myeloma Part 3 - Challenges of Diagnosis
Know What Your Doctors Know: Multiple Myeloma Part 4 - Initial Treatment
Know What Your Doctors Know: Multiple Myeloma Part 5 - Stem Cell Transplants
Know What Your Doctors Know: Multiple Myeloma Part 6 - Advances in Treatment
Know What Your Doctors Know: Multiple Myeloma Part 7 - Managing Symptoms
Know What Your Doctors Know: Multiple Myeloma Part 8 - Side Effects of Treatment
Know What Your Doctors Know: Multiple Myeloma Part 9 - The Right Track
Know What Your Doctors Know: Multiple Myeloma Part 10 - Clinical Trials
Know What Your Doctors Know: Multiple Myeloma Part 11 - Resources
Know What Your Doctors Know: Multiple Myeloma Q&A - Average age of onset or diagnosis
Know What Your Doctors Know: Multiple Myeloma Q&A - Role of MRI in MGUS or smoldering myeloma
Know What Your Doctors Know: Multiple Myeloma Q&A - Enrollment in clinical trials
Know What Your Doctors Know: Multiple Myeloma Q&A - Dexamethasone
Know What Your Doctors Know: Multiple Myeloma Q&A - Bactrim for urinary tract infections (UTIs)
Know What Your Doctors Know: Multiple Myeloma Q&A - Bone lesions
Know What Your Doctors Know: Multiple Myeloma Q&A - More on the role of heredity in myeloma
Know What Your Doctors Know: Multiple Myeloma Q&A - Take-home points for primary care physicians
Know What Your Doctors Know: Multiple Myeloma Q&A - Drug reactions
Know What Your Doctors Know: Multiple Myeloma Q&A - Daratumumab as a monotherapy for myeloma
Know What Your Doctors Know: Multiple Myeloma Q&A - Lab tests used to monitor MGUS
Know What Your Doctors Know: Multiple Myeloma Q&A - Abnormal free light chains
Know What Your Doctors Know: Multiple Myeloma Q&A - The M spike and light chain myeloma
Know What Your Doctors Know: Multiple Myeloma Q&A - Prognostic value of the kappa lambda ratio
Know What Your Doctors Know: Multiple Myeloma Q&A - Serum beta-2 microglobulin
Know What Your Doctors Know: Multiple Myeloma Q&A - X-ray in identification and diagnosis of myeloma
Know What Your Doctors Know: Multiple Myeloma Q&A - MGRS
Know What Your Doctors Know: Multiple Myeloma Q&A - CAR-T cells
Know What Your Doctors Know: Multiple Myeloma Q&A - Support for bone marrow transplant patients
Know What Your Doctors Know: Multiple Myeloma Q&A - Proteasome inhibitor-associated blepharitis
Know What Your Doctors Know: Multiple Myeloma Q&A - Bisphosphonates
Know What Your Doctors Know: Multiple Myeloma Q&A - Osteonecrosis of the jaw (ONJ)
Know What Your Doctors Know: Multiple Myeloma Q&A - Monitoring response to treatment
Know What Your Doctors Know: Multiple Myeloma Q&A - Length of treatment